纳米表面乳房植入物初次隆乳六年前瞻性结局
6年随访无包膜挛缩、破裂、双包膜或迟发性血清肿,MRI未见植入物相关并发症,3例翻修均为美学原因,患者与医生满意度高。
要点
- 6年随访无包膜挛缩、破裂、双包膜或迟发性血清肿发生。
- MRI评估未发现植入物相关并发症迹象。
- 3例翻修手术均为美学原因,无因医疗原因更换假体。
核心结论
- SmoothSilk/SilkSurface Motiva植入物在初次隆乳中6年随访显示良好的安全性和有效性。
主要发现
- 6年随访期间无包膜挛缩、破裂、双包膜或迟发性血清肿发生。
- MRI评估未发现植入物相关并发症迹象。
- 共进行3例翻修手术,均为美学原因,无因医疗原因更换假体。
- 患者和医生在所有随访访视中满意度均高。
- 患者生活质量评分在术后72个月平均提高0.89%。
关键数值与推荐
- 71.9%的植入物经乳房下皱襞切口置于胸肌下。
临床怎么用
- SmoothSilk/SilkSurface Motiva植入物可用于初次隆乳,6年随访安全性良好。
- 术后随访中患者和医生满意度高,生活质量有所提升。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Motiva Implants (Establishment Labs Holdings Inc.) are a novel family of silicone breast implants using cutting-edge technologies engineered to optimize aesthetic and safety outcomes. OBJECTIVES: The authors sought to prospectively evaluate the safety and effectiveness of SmoothSilk/SilkSurface Motiva Implants over long-term follow-up. METHODS: Surgeons at a single plastic surgery center undertook a 10-year follow-up study of SmoothSilk/SilkSurface Motiva Implants in women who underwent primary breast augmentation. Safety was assessed through identification of complications on follow-up and through magnetic resonance imaging (MRI) in a representative sample. Effectiveness outcomes were assessed by surgeons and patients using Likert scales and a Quality of Life tool. RESULTS: This article reports the 6-year safety and effectiveness outcomes. A total of 35 patients were implanted between September and December 2010, and 71.9% of implants were placed submuscularly using inframammary incision. During the 6-year follow-up, there were no occurrences of capsular contracture, rupture, double capsules, or late seroma. MRI evaluation identified no signs of implant-related complications. Three revision surgeries were performed, all for aesthetic reasons; there were no implant replacements for medical reasons. The level of satisfaction for both patients and surgeons was high at all follow-up visits. Patient quality-of-life scores increased following breast augmentation by an average of 0.89% at 72 months. CONCLUSIONS: The results of this prospective long-term follow-up study demonstrate the excellent safety and effectiveness of SmoothSilk/SilkSurface Motiva Implants in primary breast augmentation through 6 years of follow-up.
引用
- Quirós MC, Bolaños MC, Fassero JJ, et al. Six-Year Prospective Outcomes of Primary Breast Augmentation With Nano Surface Implants. Aesthet Surg J. 2019. PMID: 30423014. doi:10.1093/asj/sjy196
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。